NDAC’s Wood To Join Private Rx Investment Firm
This article was originally published in The Pink Sheet Daily
Executive Summary
Nonprescription Drugs Advisory Committee Chair Alastair Wood will join Symphony Capital, which specializes in biopharmaceutical investments.
You may also be interested in...
Lexicon Could Receive Up To $610 Million In Funding From Invus, Symphony
Infusion of venture capital will allow Lexicon to delay commercialization partnerships until its small molecule pipeline is more mature, firm says.
Energizer Grows Personal Care With Acquisition Of Leading Sun-Care Brands
Energizer Holdings will gain Banana Boat and Hawaiian Tropic - the No. 2- and No. 4-selling sun- care brands, respectively - through its $1.9 billion purchase of Playtex Products, the companies announce July 12